Latest News

Outstanding researchers from the DZHK receive the renowned ERC Advanced Grant 2022.

Scientists show in the animal model that the messenger CXCL12 could be suitable as a target structure for the therapy of blood clotting disorders.

Selected Program Items

So far, there are only a few medicines for heart failure patients with cardiac arrhythmias. Those that are approved often have severe side effects. Scientists have uncovered a mechanism that leads to arrhythmias. In the animal model, they succeeded in switching off the mechanism....

DZHK Board Spokesperson Prof. Dr. Stefanie Dimmeler has been awarded with the Otto Warburg Medal of the Society for Biochemistry and Molecular Biology for her groundbreaking work in the field of cardiovascular diseases.

World's largest study reveals risks

Prof. Dr. Dagmar Krefting is the new director of the Institute of Medical Informatics at the University Medical Center Göttingen. In September 2019, she had already taken over as acting director of the institute. Since 1 September 2021, the DZHK scientist has held the university...

The newly developed risk score predicts the 1-year risk of severe bleeding for patients after inpatient treatment for the symptomatic peripheral arterial disease (PAVK). Scientists from the University Medical Center Hamburg-Eppendorf (UKE) were involved in developing the score.

The current standard diagnostic test for intermediate-risk patients is is a minimally invasive catheter examination.Under the leadership of Charité – Universitätsmedizin Berlin, researchers from 31 European clinical institutions worked together to test cardiac CT as a...

On February 15, 2022, the Clinic for Rhythmology was founded at the Lübeck Campus of the University Hospital Schleswig-Holstein (UKSH). In this course, the Department of Electrophysiology of the Medical Clinic II was dissolved. Given the increasing specialization within...